['Separately, KeyCorp raised their price objective on shares of West Pharmaceutical Services from $350.00 to $475.00 and gave the stock an “overweight” rating in a research note on Friday, July 30th.', '\n\n\n\n\n\n                 Shares of WST stock opened at $446.96 on Friday. The stock has a market capitalization of $33.07 billion, a price-to-earnings ratio of 65.35, a price-to-earnings-growth ratio of 1.98 and a beta of 0.99. The company’s 50 day simple moving average is $397.26. The company has a current ratio of 3.13, a quick ratio of 2.39 and a debt-to-equity ratio of 0.12. West Pharmaceutical Services, Inc. has a 52-week low of $253.85 and a 52-week high of $450.90. ', 'West Pharmaceutical Services (NYSE:WST) last issued its quarterly earnings data on Thursday, July 29th. The medical instruments supplier reported $2.46 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.74 by $0.72. West Pharmaceutical Services had a net margin of 20.58% and a return on equity of 28.58%.  On average, analysts anticipate that  West Pharmaceutical Services, Inc. will post 8 EPS for the current fiscal year. ', 'About West Pharmaceutical Services', 'West Pharmaceutical Services, Inc manufactures and markets pharmaceuticals, biologics, vaccines and consumer healthcare products. It operates through the following business segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers proprietary packaging, containment and drug delivery products, along with analytical lab services, to biologic, generic and pharmaceutical drug customers.', 'Read More: What is a back-end load?\n', 'Want to see what other hedge funds are holding WST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for West Pharmaceutical Services, Inc. (NYSE:WST).', '', '', "Receive News & Ratings for West Pharmaceutical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services and related companies with MarketBeat.com's FREE daily email newsletter.", 'Russell Investments Group Ltd. Buys 18,764 Shares of PulteGroup, Inc. (NYSE:PHM)']


